SOPHiA GENETICS SA PE Ratio 2020-2023 | SOPH
Current and historical p/e ratio for SOPHiA GENETICS SA (SOPH) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SOPHiA GENETICS SA PE ratio as of May 07, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| SOPHiA GENETICS SA PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-07 | 4.97 | 0.00 | |
| 2023-12-31 | 4.71 | $-1.22 | 0.00 |
| 2023-09-30 | 2.55 | $-1.07 | 0.00 |
| 2023-06-30 | 4.48 | $-1.22 | 0.00 |
| 2023-03-31 | 4.97 | $-1.28 | 0.00 |
| 2022-12-31 | 2.06 | $-1.37 | 0.00 |
| 2022-09-30 | 2.63 | $-1.48 | 0.00 |
| 2022-06-30 | 3.62 | $-1.47 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.324B | $0.062B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.170B | 20.41 |
| Inspire Medical Systems (INSP) | United States | $7.442B | 0.00 |
| Axonics (AXNX) | United States | $3.438B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.304B | 0.00 |
| 10x Genomics (TXG) | United States | $3.115B | 0.00 |
| Azenta (AZTA) | United States | $3.074B | 250.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.887B | 0.00 |
| Enovis (ENOV) | United States | $2.865B | 21.24 |
| Hims & Hers Health (HIMS) | United States | $2.646B | 0.00 |
| Privia Health (PRVA) | United States | $2.284B | 101.32 |
| Schrodinger (SDGR) | United States | $1.715B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.10 |
| Phreesia (PHR) | United States | $1.274B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.688B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.638B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.400B | 0.00 |
| Pulmonx (LUNG) | United States | $0.370B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.367B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.225B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.210B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.161B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.09 |
| 111 (YI) | China | $0.098B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.067B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |